Cleviprex is a Intravenous Emulsion in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Clevidipine.
| Product ID | 10122-612_04948b75-fd66-48df-8b8b-8930c1ec5de5 | 
| NDC | 10122-612 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Cleviprex | 
| Generic Name | Clevipidine | 
| Dosage Form | Emulsion | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2008-09-15 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA022156 | 
| Labeler Name | Chiesi USA, Inc. | 
| Substance Name | CLEVIDIPINE | 
| Active Ingredient Strength | 1 mg/mL | 
| Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2008-09-15 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA022156 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2008-09-15 | 
| Marketing Category | NDA | 
| Application Number | NDA022156 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2008-09-15 | 
| Ingredient | Strength | 
|---|---|
| CLEVIDIPINE | .5 mg/mL | 
| SPL SET ID: | f9290625-b723-4eda-bab8-a97bef6041f6 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 10122-610 | Cleviprex | clevipidine | 
| 10122-611 | Cleviprex | clevipidine | 
| 10122-612 | Cleviprex | clevipidine | 
| 18124-011 | Cleviprex | clevidipine | 
| 65293-005 | Cleviprex | clevidipine | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() CLEVIPREX  90349617  not registered Live/Pending  | 
        CHIESI FARMACEUTICI S.P.A.  2020-11-30  | 
![]() CLEVIPREX  87442641  not registered Live/Pending  | 
        Chiesi Farmaceutici S.P.A.  2017-05-09  | 
![]() CLEVIPREX  77032009  3540746 Live/Registered  | 
        CHIESI FARMACEUTICI S.P.A.  2006-10-30  |